Last updated on August 2019

Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors


Brief description of study

The primary objective of this study is to obtain de-identified, clinically characterized, whole blood specimens to evaluate biomarkers associated with cancer for diagnostic assay development.

Detailed Study Description

Subjects who have been diagnosed, or who have a suspicion of diagnosis based on imaging, with any solid tumor. Subjects will have a blood sample collected at enrollment and provide medical history prior to initiation of treatment. There will be no further follow-up.

Clinical Study Identifier: NCT03662204

Find a site near you

Start Over